SMZL signature
Gene symbol . | C . | A . | M . | BCR/NFκB . | Median change . | Description . |
---|---|---|---|---|---|---|
MIG* | 4.52 | Glucose signal transduction pathway | ||||
MS4A2 | + | 4.18 | B-cell: Fc (crystallizable fragment) IgE receptor, β chain; found on the surface of mast cells and basophils | |||
UBD* | + | 3.71 | Ubiquitin D, FAT10, B-cell, and dendritic marker | |||
HLA-DMA | 3.22 | B-cell: major histocompatibility complex, class II, DM α, expressed in B-cell lysosomes, same as RING6 | ||||
ARHH* | 3.22 | Ras oncogene superfamily member, involved in translocation t(3;4) with BCL6 | ||||
SYK* | + | + | + | 3.19 | Positive effector of BCR-stimulated responses; regulation of intracellular calcium ion | |
PCDH9 | 3.09 | Member of a subfamily of calcium-dependent cell adhesion and recognition proteins of the cadherin superfamily | ||||
E2F5 | + | 2.75 | Transcriptional regulator: E2F4/E2F5 complex and p 107 act as transducers of transforming growth factor β (TGF-β) receptor signals upstream of cyclin-dependent kinase (CDK) | |||
TOSO* | + | 2.72 | Regulator of Fas-induced apoptosis in T cells | |||
SELL* | + | 2.64 | Selectin L (lymphocyte adhesion molecule 1), key for spleen lymphocyte relocalization | |||
TCL 1A* | 2.54 | Gene for α-chain of human T-cell receptor, Akt coactivator | ||||
AIM2 | 2.44 | Member of interferon-inducible gene family: expressed in spleen, small intestine, and peripheral blood leukocytes | ||||
SP140 | + | 2.37 | Lymphocyte-specific nuclear body protein, increased in myeloid precursor cell lines, undetected in nonlymphoid cell lines | |||
PFTK1 | + | 2.34 | Protein kinase activity, may play a role in meiosis | |||
LPXN* | + | + | 2.30 | Leupaxin, highly expressed in the spleen | ||
PIR121 | 2.29 | p53-inducible protein | ||||
ITM2A | 2.29 | Integral membrane protein 2A: gene expressed in human CD34+ hematopoietic stem/progenitor cells | ||||
PTPRC | + | + | + | 2.28 | CD45, key role in lymphocyte activation, required for proximal signaling events following triggering of the T - and B-cell antigen (Ag) receptors | |
NSF | 2.24 | N-ethylmalcimide-sensitive factor required for vesicle-mediated transport | ||||
PTPN1 | + | + | + | 2.23 | Protein-tyrosine phosphatase: important regulatory component in signal transduction, neoplastic transformation, and control of mitotic cycle | |
RASSF2 | + | 2.22 | Ras association domain family 2 | |||
CDW52* | 2.20 | CAMPATH-1 antigen | ||||
HLA-DMB | 2.06 | B-cell: major histocompatibility complex, class II, DM β | ||||
BIRC3* | + | + | + | 2.05 | HIAP1 (human inhibitor of apoptosis protein 1), apoptotic suppressor, interacts with tumor necrosis factor (TNF) receptor-associated factor 1 (TRAF1) and TRAF2 | |
TNFRSF5* | + | + | + | + | 2.05 | CD40, expressed in B cells, essential role for T-cell-dependent Ig class switching, memory B-cell development, and GC formation |
EIF4B | + | 2.01 | RNA-binding activity and use in the initiation of protein biosynthesis | |||
BTAF1 | + | 2.01 | Regulates transcription in association with TATA binding protein (TBP) | |||
TRAF3* | + | + | + | 2.00 | Signal transducer associated with the cytoplasmic domain of tumor necrosis factor type 2 receptor (TNF-R2); also binds to CD40 and lymphotoxin beta receptor (LTB-R) | |
TRAF5* | + | + | + | 1.99 | Interacts with LTB-R and activates NFκB | |
AMPD3 | + | 1.96 | Purine metabolism | |||
POU2AF1 | + | 1.93 | Transcriptional coactivator, essential for the Ag B-cell response and GC formation, involved in t(3;11) in a form of B-cell leukemia with BCL6 | |||
ADD3 | 1.93 | Binds to calmodulin; a t(10;11), yielding a T-cell acute lymphoblastic leukemia and myeloid markers | ||||
EGR2 | + | 1.90 | Early growth response 2, zinc finger transcription factor; DNA binding | |||
WBP1 | 1.85 | Protein-protein interaction; similar function to Src homology 3 (SH3) domain | ||||
ENPP2 | + | + | 1.80 | Autotaxin (ATX): Purine metabolism; specific target of cell transformation by v-jun | ||
BTK* | + | + | + | + | 1.71 | BCR signaling: signal transduction in B cells and other tissues, essential for B-cell activation |
PDE4B | + | 1.66 | Cyclic adenosine monophosphate (cAMP)-specific phosphodiesterase | |||
ICSBP1 | + | 1.61 | Interferon regulatory factor expressed exclusively in cells of the immune system | |||
LTB* | + | 1.54 | BCR signaling: lymphotoxin β (TNF superfamily, member 3) |
Gene symbol . | C . | A . | M . | BCR/NFκB . | Median change . | Description . |
---|---|---|---|---|---|---|
MIG* | 4.52 | Glucose signal transduction pathway | ||||
MS4A2 | + | 4.18 | B-cell: Fc (crystallizable fragment) IgE receptor, β chain; found on the surface of mast cells and basophils | |||
UBD* | + | 3.71 | Ubiquitin D, FAT10, B-cell, and dendritic marker | |||
HLA-DMA | 3.22 | B-cell: major histocompatibility complex, class II, DM α, expressed in B-cell lysosomes, same as RING6 | ||||
ARHH* | 3.22 | Ras oncogene superfamily member, involved in translocation t(3;4) with BCL6 | ||||
SYK* | + | + | + | 3.19 | Positive effector of BCR-stimulated responses; regulation of intracellular calcium ion | |
PCDH9 | 3.09 | Member of a subfamily of calcium-dependent cell adhesion and recognition proteins of the cadherin superfamily | ||||
E2F5 | + | 2.75 | Transcriptional regulator: E2F4/E2F5 complex and p 107 act as transducers of transforming growth factor β (TGF-β) receptor signals upstream of cyclin-dependent kinase (CDK) | |||
TOSO* | + | 2.72 | Regulator of Fas-induced apoptosis in T cells | |||
SELL* | + | 2.64 | Selectin L (lymphocyte adhesion molecule 1), key for spleen lymphocyte relocalization | |||
TCL 1A* | 2.54 | Gene for α-chain of human T-cell receptor, Akt coactivator | ||||
AIM2 | 2.44 | Member of interferon-inducible gene family: expressed in spleen, small intestine, and peripheral blood leukocytes | ||||
SP140 | + | 2.37 | Lymphocyte-specific nuclear body protein, increased in myeloid precursor cell lines, undetected in nonlymphoid cell lines | |||
PFTK1 | + | 2.34 | Protein kinase activity, may play a role in meiosis | |||
LPXN* | + | + | 2.30 | Leupaxin, highly expressed in the spleen | ||
PIR121 | 2.29 | p53-inducible protein | ||||
ITM2A | 2.29 | Integral membrane protein 2A: gene expressed in human CD34+ hematopoietic stem/progenitor cells | ||||
PTPRC | + | + | + | 2.28 | CD45, key role in lymphocyte activation, required for proximal signaling events following triggering of the T - and B-cell antigen (Ag) receptors | |
NSF | 2.24 | N-ethylmalcimide-sensitive factor required for vesicle-mediated transport | ||||
PTPN1 | + | + | + | 2.23 | Protein-tyrosine phosphatase: important regulatory component in signal transduction, neoplastic transformation, and control of mitotic cycle | |
RASSF2 | + | 2.22 | Ras association domain family 2 | |||
CDW52* | 2.20 | CAMPATH-1 antigen | ||||
HLA-DMB | 2.06 | B-cell: major histocompatibility complex, class II, DM β | ||||
BIRC3* | + | + | + | 2.05 | HIAP1 (human inhibitor of apoptosis protein 1), apoptotic suppressor, interacts with tumor necrosis factor (TNF) receptor-associated factor 1 (TRAF1) and TRAF2 | |
TNFRSF5* | + | + | + | + | 2.05 | CD40, expressed in B cells, essential role for T-cell-dependent Ig class switching, memory B-cell development, and GC formation |
EIF4B | + | 2.01 | RNA-binding activity and use in the initiation of protein biosynthesis | |||
BTAF1 | + | 2.01 | Regulates transcription in association with TATA binding protein (TBP) | |||
TRAF3* | + | + | + | 2.00 | Signal transducer associated with the cytoplasmic domain of tumor necrosis factor type 2 receptor (TNF-R2); also binds to CD40 and lymphotoxin beta receptor (LTB-R) | |
TRAF5* | + | + | + | 1.99 | Interacts with LTB-R and activates NFκB | |
AMPD3 | + | 1.96 | Purine metabolism | |||
POU2AF1 | + | 1.93 | Transcriptional coactivator, essential for the Ag B-cell response and GC formation, involved in t(3;11) in a form of B-cell leukemia with BCL6 | |||
ADD3 | 1.93 | Binds to calmodulin; a t(10;11), yielding a T-cell acute lymphoblastic leukemia and myeloid markers | ||||
EGR2 | + | 1.90 | Early growth response 2, zinc finger transcription factor; DNA binding | |||
WBP1 | 1.85 | Protein-protein interaction; similar function to Src homology 3 (SH3) domain | ||||
ENPP2 | + | + | 1.80 | Autotaxin (ATX): Purine metabolism; specific target of cell transformation by v-jun | ||
BTK* | + | + | + | + | 1.71 | BCR signaling: signal transduction in B cells and other tissues, essential for B-cell activation |
PDE4B | + | 1.66 | Cyclic adenosine monophosphate (cAMP)-specific phosphodiesterase | |||
ICSBP1 | + | 1.61 | Interferon regulatory factor expressed exclusively in cells of the immune system | |||
LTB* | + | 1.54 | BCR signaling: lymphotoxin β (TNF superfamily, member 3) |
The most highly expressed genes in the SMZL series are shown. The functional signatures cell communication (C), apoptosis (A), metabolism (M), and BCR/NF-κB activation are indicated with “+”.
The most important genes.